Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Y-mAbs Therapeutics | YMAB | Mar 27, 2024 | 16.50 | +5.10 |
Yalla ADR | YALA | Mar 27, 2024 | 4.77 | +0.42 |
Yatra Online | YTRA | Mar 27, 2024 | 1.63 | +1.24 |
Yatsen ADR | YSG | Mar 27, 2024 | 2.11 | +3.94 |
Yelp | YELP | Mar 27, 2024 | 39.10 | +2.22 |
YETI | YETI | Mar 27, 2024 | 38.34 | +3.85 |
Yext | YEXT | Mar 27, 2024 | 6.04 | +1.51 |
Yield10 Bioscience | YTEN | Mar 27, 2024 | 0.38 | +9.61 |
Yieldshares High Income ETF | YYY | Mar 27, 2024 | 11.98 | +0.42 |
Yiren Digital ADR | YRD | Mar 27, 2024 | 4.51 | -3.63 |
York Water | YORW | Mar 27, 2024 | 35.97 | +1.87 |
Yoshiharu Global A | YOSH | Mar 27, 2024 | 4.02 | +0.52 |
Yoshitsu ADR | TKLF | Mar 27, 2024 | 0.26 | +2.16 |
Yotta Acquisition | YOTA | Mar 27, 2024 | 10.83 | 0.00 |
Yotta Acquisition Unit | YOTAU | Mar 27, 2024 | 11.61 | 0.00 |
Youdao A ADR | DAO | Mar 27, 2024 | 3.90 | +0.26 |
YPF Sociedad Anonima ADR | YPF | Mar 27, 2024 | 20.12 | +1.62 |
YS Biopharma | YS | Mar 27, 2024 | 0.71 | +12.70 |
Yum China | YUMC | Mar 27, 2024 | 38.96 | -0.20 |
Yum! Brands | YUM | Mar 27, 2024 | 137.32 | +1.87 |
Yunhong Green CTI | YHGJ | Mar 27, 2024 | 1.67 | -0.60 |
Yunji ADR | YJ | Mar 27, 2024 | 0.77 | +9.93 |
Zai Lab ADR | ZLAB | Mar 27, 2024 | 16.19 | +1.50 |
Zalatoris II Acquisition | ZLS | Mar 27, 2024 | 10.84 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | Mar 27, 2024 | 0.25 | +1.68 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Mar 27, 2024 | 43.74 | +0.66 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Mar 27, 2024 | 57.69 | +0.64 |
Zebra Technologies A | ZBRA | Mar 27, 2024 | 299.16 | +2.67 |
Zedge B | ZDGE | Mar 27, 2024 | 2.71 | 0.00 |
Zentalis Pharmaceuticals | ZNTL | Mar 27, 2024 | 15.19 | +7.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.